Stimvia’s Pilot Study Shows Promise for Parkinson’s Treatment
PRAGUE, June 7, 2024 — Stimvia, a pioneering medical technology company specializing in neuromodulation for chronic disease treatment, has successfully completed its pilot study focused on Parkinson’s Disease (PD) and…